Cannenta Limited
Cannenta is a biotechnology venture developing advanced wound care products. The company has a unique angiogenic factor which can be incorporated in a range of dressing products to accelerate vascularisation in wound beds and thus provide a foundation for effective wound recovery. The technology can be applied to a range of products and indications including treatment of diabetic foot ulcers and other chronic wounds. Cannenta is working with established manufacturers to incorporate the technology into suitable product carriers and intends to distribute to a global market following a clinical development program.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Cannenta Limited
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- IR
Iain Ralph
Executive Director · General Business & Management
EmailPhone - XS
Xenia Sango
Chief Operating Officer · General Business & Management
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Cannenta Limited
2 distinct titles indexed · top 2 shown.
- 1chief operating officer
- 1executive director
Sign up to unlock all 2 contacts at Cannenta Limited
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Cannenta Limited
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.